Clinical trials are being conducted at Acadia Hospital in Bangor that is part of a new global study of the safety and effectiveness of an investigational medication in people who have normal memory function, but who might experience memory loss associated with Alzheimer’s disease in the future. Dr. Clifford Singer is conducting these important trials.

According to the latest research, one out of every eight Mainers 65 and older, is living with Alzhiemer's disease. The diagnosis for those 65 to 74 year old is expected to grow by 77% in the next decade.

Alzheimer's is a devastating disease affecting more than 5 million Americans, including 27,000 Mainers. Jackson Lab and the Alzheimer's Association held a panel discussion in Bangor Friday about the illness and the advancements made.